Thymalin as an immunomodulation option in severe COVID-19

被引：1
|
作者：
Lukyanov, Sergey [1 ]
Shapovalov, Konstantine [1 ]
Tereshkov, Pavel [1 ]
Smolyakov, Yuri [1 ]
Vanchikova, Ayagma [1 ]
Kuznik, Boris [1 ]
机构：
[1] Chita State Med Acad, Chita Zabaykalsky Krai, Moscow, Russia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2021年 / 58卷
关键词：
Covid-19; Critically ill patients; Immunosuppression;
D O I：
10.1183/13993003.congress-2021.PA3667
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3667
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Tocilizumab in severe COVID-19
    Liberato, Nicola Lucia
    De Monte, Andrea
    Caravella, Giuseppe
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (06) : 1457 - 1458
  • [32] Immunomodulation of COVID-19 severity by helminth co-infection: Implications for COVID-19 vaccine efficacy
    Akelew, Yibeltal
    Andualem, Henok
    Ebrahim, Endris
    Atnaf, Aytenew
    Hailemichael, Wasihun
    [J]. IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (03)
  • [33] Timing of COVID-19 Vaccination and Rates of Severe COVID-19 Infection
    Kucirka, Lauren
    Lessler, Justin
    Manuck, Tracy
    [J]. OBSTETRICS AND GYNECOLOGY, 2023, 141 : 73S - 73S
  • [34] COVID-19: Rare variants increase the risk of severe COVID-19
    van de Veerdonk, Frank L.
    Netea, Mihai G.
    [J]. ELIFE, 2021, 10
  • [35] Alternative Medicine as a Treatment Option for COVID-19
    Marzan, Mahfuza
    Rahman, Md. Shahedur
    Jamal, Md. Abu Hena Mostofa
    Shariare, Mohammad Hossain
    Parvez, Md. Anowar Khasru
    [J]. CURRENT TRADITIONAL MEDICINE, 2021, 7 (04) : 559 - 565
  • [36] The convalescent sera option for containing COVID-19
    Casadevall, Arturo
    Pirofski, Liise-Anne
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (04): : 1545 - 1548
  • [37] Clinical research and COVID-19: Science is not an option
    不详
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (09): : E72 - E73
  • [38] The COVID-19 risk in the Chinese option market
    Li, Jianhui
    Ruan, Xinfeng
    Gehricke, Sebastian A.
    Zhang, Jin E.
    [J]. INTERNATIONAL REVIEW OF FINANCE, 2022, 22 (02) : 346 - 355
  • [39] Doxycycline: a new treatment option for COVID-19
    Anwar, Ismail
    Anwer, Eman Kamal El-dien
    AbdAllah, Mohamed
    [J]. ALEXANDRIA JOURNAL OF MEDICINE, 2020, 56 (01) : 130 - 131
  • [40] Remdesivir as a possible therapeutic option for the COVID-19
    Al-Tawfiq, Jaffar A.
    Al-Homoud, Ali H.
    Memish, Ziad A.
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 34
12345